A total of six types of tumor immune cells including B cell, CD8+ T cell, CD4+ T cell, macrophage, neutrophil, and dendritic cell were analyzed for the correlation with GXYLT2 expression in BLCA. The gene discussed is CD8A; the disease is neoplasm.